Coronavirus Strain In India

Coronavirus News Updates: Odisha prohibits New Year celebrations, allows reopening of cinema, theatre halls from 1 Jan

Coronavirus News Updates: Cinema hall, theatres have been allowed to reopen with up to 50 percent capacity and social, religious, sports and cultural functions and gatherings will be allowed with a ceiling of 200 people, said an order

Coronavirus News Updates: Schools, colleges in Mumbai to remain shut till 15 Jan, says BMC

Coronavirus News Updates: The decision was taken due to the second wave of COVID-19 in other countries and the situation in some states in India, the civic body said in a circular

India detects six cases of new COVID-19 variant after UK returnees test positive

Three of the patients are in NIMHANS, Bengaluru, two in Centre for Cellular & Molecular Biology, Hyderabad and one in National Institute of Virology, Pune, said the health ministry

Coronavirus News Updates: One UK returnee tests positive in Maharashtra's Thane; 355 new cases reported in district

Coronavirus News LIVE Updates: As many as 55 people have returned to the areas under KDMC limits from the UK from 25 November onwards, the civic body said

Coronavirus News Updates: Karnataka govt says 10 UK returnees have tested COVID-19 positive in state so far

Coronavirus News LIVE Updates: Reportedly, the patients' samples have been sent for genetic sequencing to find out whether it is a new strain of virus that has infected them

Coronavirus News Updates: Seven UK returnees found COVID-19 positive in Telangana, hospitalised

Coronavirus News Updates: An official release from Health Minister E Rajender said so far 1,200 people had come to Telangana from or via the United Kingdom since 12 December and efforts were on to trace people who came in contact with those found positive.

Coronavirus News Updates: Covaxin displaying encouraging results in clinical trial, claims Bharat Biotech

Coronavirus News Updates: Covaxin, being developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is now undergoing Phase 3 trials